Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2012
10/02/2012US8277841 Polyamide rate-modulated monolithic drug delivery system
10/02/2012US8277840 Sustained release formulation of alprazolam
10/02/2012US8277839 Oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof
10/02/2012US8277838 Transdermal delivery of drugs based on crystal size
10/02/2012US8277837 Hemostatic textile
10/02/2012US8277831 Using pemirolast ; antiscarring agents
10/02/2012US8277829 Nano/macroporous bone tissue scaffolds for regenerative medicine
10/02/2012US8277824 Solubilization of cyclohexane-based carboxamide derivatives for use as sensates in consumer products
10/02/2012US8277801 Delivery system for functional compounds
10/02/2012US8277782 Antiinflammatory agent, metalloproteinase inhibitor, anti-oxidant and modifier of cell redox status, vitamins, inhibitor of activation of nuclear factor kappa beta
10/02/2012US8277781 Device for intranasal administration
10/02/2012US8277780 Stable liquid desoximethasone compositions with reduced oxidized impurity
10/02/2012US8277441 Piezoelectric transducer
10/02/2012US8277440 Implantable device for controlled, extended delivery of parathyroid hormone
10/02/2012CA2672427C Colon cleansing compositions
10/02/2012CA2669457C Calcium-containing structures and methods of making and using the same
10/02/2012CA2641451C Polymer formulations of cetp inhibitors
10/02/2012CA2553890C Pharmaceutical compositions comprising midazolam in a high concentration
10/02/2012CA2552266C Continuous method for producing bioactive molecule coated particles, bioactive molecule coated particles and uses therefor
10/02/2012CA2550841C Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases
10/02/2012CA2531486C Saquinavir mesylate oral dosage form
10/02/2012CA2513201C Capsule for receiving an active substance which is administrable by inhalation
10/02/2012CA2507368C Orifice device having multiple channels with varying flow rates for drug delivery
10/02/2012CA2490321C Method and apparatus for manufacturing aspheric seamless capsule
10/02/2012CA2489064C Pharmaceutical dosage form and method for the production thereof
10/02/2012CA2483212C Coated particles with prolonged release and tablets containing same
10/02/2012CA2481739C Sustained release of guaifenesin combination drugs
10/02/2012CA2470601C Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
10/02/2012CA2467215C Emulsion compositions
10/02/2012CA2453676C Thermotherapy via targeted delivery of nanoscale magnetic particles
10/02/2012CA2412795C Improved liposomal camptothecins and uses thereof
10/01/2012CA2772416A1 Nicotine-containing patch preparation
09/2012
09/27/2012WO2012129576A2 System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
09/27/2012WO2012129568A2 Lithium compositions
09/27/2012WO2012129551A1 Methods and compositions for treatment of attention deficit disorder
09/27/2012WO2012129499A1 Treatment of inflammatory and infectious skin disorders
09/27/2012WO2012129497A2 Swallowable medication capsule
09/27/2012WO2012129429A2 Transdermal compositions comprising an active agent layer and an active agent conversion layer
09/27/2012WO2012129156A1 Pharmaceutical compositions comprising sorbitan esters
09/27/2012WO2012129099A1 Formulations of phenyl uracil compounds
09/27/2012WO2012129072A1 Solid particulate compositions comprising coenzyme q10
09/27/2012WO2012129057A2 Ssh-2 (slingshot-2) inhibitors and methods for making and using them
09/27/2012WO2012129047A1 Oral administration of melanin for protection against radiation
09/27/2012WO2012129024A2 Compositions for encapsulating biomaterials and uses related thereto
09/27/2012WO2012128786A2 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
09/27/2012WO2012128589A2 Urethane foam for use in impregnating cosmetic composition
09/27/2012WO2012128587A2 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
09/27/2012WO2012128520A2 Liquid-type composition for treating gastroesophageal reflux disease
09/27/2012WO2012128417A1 Water-soluble cationic-drug delivery system having a sustained-release mechanism
09/27/2012WO2012128394A1 A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
09/27/2012WO2012128326A1 Nanoparticles for photo dynamic therapy
09/27/2012WO2012127927A1 Medical device for controlled release of drug
09/27/2012WO2012127497A1 Stable pharmaceutical compositions of ketorolac or salts thereof
09/27/2012WO2012127496A1 Stable pharmaceutical compositions of lornoxicam or salts thereof
09/27/2012WO2012127431A1 Stabilized compositions of tetrahydrobiopterin
09/27/2012WO2012127407A1 Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid
09/27/2012WO2012127392A1 Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
09/27/2012WO2012127381A1 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
09/27/2012WO2012127105A2 Method for preparation of microcapsules from hemicellulose
09/27/2012WO2012127048A1 Solid pharmaceutical composition comprising donepezil
09/27/2012WO2012127037A2 A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
09/27/2012WO2012126966A2 Optimised preparations of highly adaptable aggregates
09/27/2012WO2012126965A1 Drug-free compositions and methods for diminishing peripheral inflammation and pain
09/27/2012WO2012126941A1 A composition and method
09/27/2012WO2012126931A1 Pharmaceutical formulation comprising inositol
09/27/2012WO2012126813A1 Solid ambroxol-containing preparation
09/27/2012WO2012126770A1 Doxylamine resinate complex
09/27/2012WO2012126278A1 Terbinafine reverse thermo-sensitive reversible aquagel composition
09/27/2012WO2012126277A1 External reverse thermo-sensitive reversible aquagel composition for treating hair loss
09/27/2012WO2012126231A1 Use of poly(4-styrene sulfonic acid-copoly-maleic acid) sodium salt and pharmaceutical composition thereof
09/27/2012WO2012126140A1 Reversely thermo-reversible hydrogel compositions
09/27/2012WO2012126115A1 Star polymer nanoshells and methods of preparation thereof
09/27/2012WO2012103985A3 Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications
09/27/2012WO2012099962A3 Pharmaceutical compositions and methods for making and using them
09/27/2012WO2012097763A3 A carrier for oromucosal, especially sublingual administration of physiologically active substances
09/27/2012WO2012097255A3 Therapeutic effect of heat shock proteins in preventing amylin aggregation in type 2 diabetes mellitus
09/27/2012WO2012092628A3 Patches and methods for the transdermal delivery of agents to treat hair loss
09/27/2012WO2012087257A3 Oral dosage form comprising imatinib and production of said oral dosage form
09/27/2012WO2012087256A3 Pharmaceutical capsule formulations
09/27/2012WO2012075244A3 Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
09/27/2012WO2012069658A4 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders
09/27/2012WO2012030927A3 Modified-release dosage forms of 5-ht2c agonists useful for weight management
09/27/2012WO2012020261A3 Structures for transdermal drug delivery
09/27/2012WO2011141926A3 Liquid formulation of polypeptides containing an fc domain of an immunoglobulin
09/27/2012US20120245540 Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
09/27/2012US20120245419 Devices, Systems and Methods For Diagnosing and Treating Sinusitis and Other Disorders of the Ears, Nose and/or Throat
09/27/2012US20120245207 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245027 Microcapsules with acetylene carbamide-polyurea polymers and formulations thereof for controlled release
09/27/2012US20120244225 Au-Ag Core-Shell Nanorod Particles and Method for Producing Same
09/27/2012US20120244224 NANOSTRUCTURAL MATERIALS THAT INCREASE MINERALIZATION IN BONE CELLS AND AFFECT GENE EXPRESSION THROUGH miRNA REGULATION AND APPLICATIONS OF SAME
09/27/2012US20120244223 Orally dispersible tablet
09/27/2012US20120244222 Osmotic mediated release synthetic nanocarriers
09/27/2012US20120244221 Extended-release formulation for reducing the frequency of urination and method of use thereof
09/27/2012US20120244220 Atrovastatin-containing coated preparation
09/27/2012US20120244219 Stable benzimidazole formulation
09/27/2012US20120244218 Calcium supplement
09/27/2012US20120244217 4-methylpyrazole formulations
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244215 High-strength testosterone undecanoate compositions
1 ... 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 ... 2991